These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15700025)

  • 1. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S; Gutkowska J
    Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic imidazoline receptor activation in spontaneously hypertensive rats.
    Menaouar A; El-Ayoubi R; Jankowski M; Gutkowska J; Mukaddam-Daher S
    Am J Hypertens; 2002 Sep; 15(9):803-8. PubMed ID: 12219876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
    Gutkowska J; Mukaddam-Daher S; Tremblay J
    J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
    Mukaddam-Daher S; Lambert C; Gutkowska J
    Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
    Mukaddam-Daher S; Gutkowska J
    Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C; Kang CW; Kim SZ; Kim SH
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
    Hohage H; Hess K; Jahl C; Greven J; Schlatter E
    Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxonidine into the lateral parabrachial nucleus reduces renal and hormonal responses to cell dehydration.
    Andrade CA; Margatho LO; Andrade-Franzé GM; De Luca LA; Antunes-Rodrigues J; Menani JV
    Neuroscience; 2012 Apr; 208():69-78. PubMed ID: 22373877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):446-51. PubMed ID: 15075383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
    Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
    Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.